IRIS
FALOPPI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
EU - Europa 1.391
AS - Asia 1.231
SA - Sud America 378
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 92
OC - Oceania 1
Totale 6.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.271
SG - Singapore 429
BR - Brasile 305
IT - Italia 269
VN - Vietnam 229
CN - Cina 213
RU - Federazione Russa 211
UA - Ucraina 199
SE - Svezia 130
DE - Germania 125
TR - Turchia 114
IE - Irlanda 111
FI - Finlandia 80
DK - Danimarca 76
FR - Francia 68
GB - Regno Unito 66
HK - Hong Kong 62
KR - Corea 43
IN - India 37
CI - Costa d'Avorio 34
BD - Bangladesh 31
CA - Canada 29
MX - Messico 25
MA - Marocco 24
AR - Argentina 20
JP - Giappone 19
NL - Olanda 17
ZA - Sudafrica 16
EC - Ecuador 15
ES - Italia 14
ID - Indonesia 11
IQ - Iraq 11
CO - Colombia 10
VE - Venezuela 9
CL - Cile 8
DZ - Algeria 8
MY - Malesia 8
PL - Polonia 6
KE - Kenya 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.439
Salva come PNG Salva come JPEG
Città #
Ashburn 599
Singapore 268
Chandler 253
Fairfield 219
Jacksonville 211
San Jose 153
Dallas 128
Wilmington 125
Council Bluffs 120
Dublin 110
Boardman 100
New York 94
Seattle 94
Woodbridge 89
Ho Chi Minh City 75
Centro 73
Houston 72
Cambridge 66
Ann Arbor 61
Hong Kong 58
Beijing 57
Los Angeles 56
Hanoi 55
Des Moines 53
The Dalles 48
Lawrence 44
Moscow 44
Princeton 44
San Mateo 44
Lauterbourg 38
Turin 36
Abidjan 33
Munich 24
Helsinki 23
Milan 23
São Paulo 23
Orem 20
London 19
Tokyo 19
Turku 18
Chicago 17
Hefei 17
San Diego 16
Chennai 15
Atlanta 13
Montreal 13
Santa Clara 13
Buffalo 12
Johannesburg 11
Rio de Janeiro 11
Amsterdam 9
Frankfurt am Main 9
Guayaquil 9
Manchester 9
Pune 9
Columbus 8
Denver 8
Izmir 8
Mexico City 8
Paris 8
Stockholm 8
Wuxi 8
Brasília 7
Fortaleza 7
Phoenix 7
Porto Alegre 7
San Francisco 7
Belo Horizonte 6
Brooklyn 6
Da Nang 6
Santiago 6
Washington 6
Bến Tre 5
Curitiba 5
Montevideo 5
Norwalk 5
Poplar 5
Shanghai 5
St Petersburg 5
Warsaw 5
Bogotá 4
Cagliari 4
Campinas 4
Charlotte 4
Dhaka 4
Fayetteville 4
Florence 4
Haiphong 4
Kilburn 4
Madrid 4
Miano 4
Mumbai 4
Nairobi 4
New Delhi 4
Portland 4
Thái Nguyên 4
Toronto 4
Venice 4
Wuhan 4
Ancona 3
Totale 4.112
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 226
Immunotherapy in genitourinary cancers: Where are we going? 212
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 204
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 201
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 200
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 198
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 176
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 173
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 169
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 166
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 166
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 165
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 162
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 160
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 160
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 157
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 155
Panitumumab for the treatment of metastatic colorectal cancer: A review 152
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 147
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 147
Trattamento del carcinoma del pancreas. Attualità e prospettive 147
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 145
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 142
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 142
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 142
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 140
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 139
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 137
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 136
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 134
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 133
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 132
Palliative treatment 129
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 129
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 125
Selecting the best treatment for an individual patient. 125
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 120
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 113
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Gastric cancer: Therapeutic choices in advanced disease 111
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology 109
Cetuximab: still an option in the treatment of pancreatic cancer? Expert Opin Biol Ther. 2013 May;13(5):791-801 103
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 95
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 93
Totale 6.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022240 0 0 0 6 2 23 15 24 20 54 26 70
2022/2023745 51 105 58 55 47 119 1 44 168 3 78 16
2023/2024388 59 4 39 50 60 104 6 4 1 6 7 48
2024/2025801 112 71 12 11 49 29 102 31 141 58 100 85
2025/20262.410 151 223 134 265 313 164 381 219 168 221 68 103
2026/2027259 96 66 76 21 0 0 0 0 0 0 0 0
Totale 6.528